Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma

Author(s)

Soares, M. R. ^[1] ; Huber, J. ; Rios, A. F. L. ^[2] ; Ramos, E. S. ^{[1, 3]}

Affiliation

^[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Gynecol & Obstet, BR-14049900 Sao Paulo - Brazil

^[2] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Rio De Janeiro - Brazil

^[3] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sch Med Ribeirao Preto, BR-14049900 Sao Paulo - Brazil

• Document type: Journal article
• Source: GROWTH HORMONE & IGF RESEARCH; v. 20, n. 4, p. 295-297, AUG 2010.
• Web of Science Citations: 10

Abstract

Objective: The etiology of cutaneous melanoma is complex, involving both heterogeneous genetic and environmental components. The aim of our study was to verify if single polymorphic sites within IGF2 and H19 genes and their consequent haplotypes influence risk and/or prognosis of familial melanoma. Design: Twenty one patients with clinical criteria of hereditary melanoma (early onset, presence of multiple primary melanoma, and/or one or more affected first- or second-degree relatives) and previously screened for CDKN2A mutations were genotyped by IGF2/ApaI and H19/RsaI PCR-RFLPs. Data were compared between patients and a control group (100 healthy young individuals) using Chi-square and Fisher's exact tests. We also investigated if these polymorphic sites could be microRNAs potential targets, using RegRNA software. Results: Although the IGF2 and HI9 genotypes/haplotypes were not significantly associated with melanoma, two of the most severe cases (very early onset or multiple melanomas) showed to be heterozygous for both genes. We found an overlap between IGF2/ApaI and miR-615-5p, and between H19/RsaI and miR-574-3p. Conclusions: Some studies have shown H19, and IGF2 genes (or related genes or protein, for example, IGF2R and IMP-3) differential expression in melanoma. However, no study has attempted to examine markers across this cluster in relation to melanoma until now. Since the base change may impair the pairing of microRNA and its binding site, our results suggest a new window for future studies of IGF2 and H19 genetic variability and posttranscriptional regulation. Due to the importance and based on the present results, we suggest that the genotype/haplotype analysis of IGF2 and H19 polymorphisms should be better investigated in large populations with cutaneous melanoma, attempting to tie the association with progression of the disease. (C) 2010 Growth Hormone Research Society. Published by Elsevier Ltd. All rights reserved. (AU)

• FAPESP's process: 07/01911-6 - Analysis of CDKN1C gene variants and pre-eclampsia
• Grantee: Murilo Racy Soares
• Support Opportunities: Scholarships in Brazil - Master
• FAPESP's process: 09/08313-2 - Methylation pattern and differential MHM region expression during chicken gonadal development
• Grantee: Ester Silveira Ramos
• Support Opportunities: Regular Research Grants